Essex Woodlands Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123M Hold
13,021,324
48.35% 1
2026
Q1
$119M Hold
13,021,324
47.45% 1
2025
Q4
$96.9M Hold
13,021,324
30.44% 2
2025
Q3
$87.1M Hold
13,021,324
28.36% 2
2025
Q2
$86.2M Hold
13,021,324
30.88% 2
2025
Q1
$119M Hold
13,021,324
34.37% 2
2024
Q4
$137M Hold
13,021,324
31.56% 2
2024
Q3
$156M Hold
13,021,324
44.41% 2
2024
Q2
$74.9M Hold
13,021,324
24.41% 2
2024
Q1
$67.7M Hold
13,021,324
19.64% 2
2023
Q4
$68.6M Hold
13,021,324
16.98% 2
2023
Q3
$43M Hold
13,021,324
37.88% 1
2023
Q2
$37.6M Buy
13,021,324
+924,622
+8% +$1.77M 28.48% 2
2023
Q1
$12.9M Hold
12,096,702
7.49% 4
2022
Q4
$31.6M Hold
12,096,702
17.6% 3
2022
Q3
$84.7M Hold
12,096,702
34.99% 1
2022
Q2
$82.5M Hold
12,096,702
34.1% 1
2022
Q1
$171M Hold
12,096,702
41.24% 1
2021
Q4
$175M Hold
12,096,702
39.42% 1
2021
Q3
$171M Hold
12,096,702
38.01% 1
2021
Q2
$213M Hold
12,096,702
31.45% 2
2021
Q1
$185M Buy
+12,096,702
New +$172M 28.89% 2

Other funds holding BVS

Essex Woodlands Management's BVS Position: Q2 2026 in Review

Essex Woodlands Management held its Bioventus (BVS) position steady in Q2 2026 at 13,021,324 shares worth $123M. The position accounts for 48.35% of the portfolio, ranked #1.

Essex Woodlands Management first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $213M in Q2 2021. 61 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Essex Woodlands Management held 13,021,324 shares of Bioventus worth $123M as of Q2 2026.
  • Essex Woodlands Management left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up 48.35% of Essex Woodlands Management's portfolio in Q2 2026, its #1 holding.
  • Essex Woodlands Management first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • Essex Woodlands Management's Bioventus position peaked at $213M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Essex Woodlands Management's 13F filing for Q2 2026, filed 4 Aug 2026.